跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LYVDELZI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LYVDELZI
Authorized
STANDARD
LYVDELZI
GILEAD SCIENCES CANADA INC
🇨🇦 Health Canada
Approval Date
Feb 6, 2026
Approval ID
5bd38d62fa47ccf5
Company
GILEAD SCIENCES CANADA INC
Type
Standard
Approval Details
Approval Id
5bd38d62fa47ccf5
Drug Approval Canada Name
LYVDELZI
Product Name
LYVDELZI
Status
Marketed
Status Date
2025-11-25
Original Market Date
2025-11-25
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:14.00
Atc Original
A05AX07 SELADELPAR
Aig Number
0167734001
Company Name
GILEAD SCIENCES CANADA INC
Company Address
400 6925 Century Avenue Mississauga Ontario Canada L5N 7K2
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 6, 2026
Approval ID
5bd38d62fa47ccf5
Type
Standard
Back to Health Canada Approvals